RegenPRP®

the platelet concentrate prepared with RegenLab® technology provides an autologous reservoir of growth factors.

What is RegenPRP® ?

1.1 – Platelets

In addition to their role in haemostasis, are key factors in tissue repair mechanisms.1 They provide essential growth factors, such as FGF, PDGF, TGF-β, EGF, VEGF, IGF, which are involved in stem cell migration, differentiation and proliferation. Platelet growth factors also stimulate fibroblasts and endothelial cells to induce the deposition of new extracellular matrix and neo-vascularisation, respectively.

1.2 – Plasma

Contains many factors essential for cell survival including nutrients, vitamins, hormones, electrolytes, growth factors (such as IGF and HGF), and proteins. Among the plasma proteins, the molecules vital for the coagulation process and for formation of the fibrin polymer will serve as a scaffold for cell migration and new tissue generation.2

1.3 – Platelet Rich Plasma (PRP)

  • Proven role in the healing of tissues, with key roles in cell migration, proliferation and differentiation
  • Mechanism of action comprises anti-inflammatory activity and activation of cell-signalling cascades
  • Key role in the synthesis of new extracellular matrix for tissue regeneration

1.4 – RegenKit® Technology

The RegenKit®-BCT are medical devices intended for the preparation of RegenPRP®. They contain Regen BCT tubes. Regen BCT tubes are made of pharmaceutical grade glass with a vacuum for automated blood collection. They contain a sodium citrate anticoagulant solution and a separator gel to separate plasma and platelets from the blood cells and produce RegenPRP® with a standardised composition.

Technology advantages

  • User-independent standardised preparation
  • Minimum volume of blood required
  • Safe closed-circuit system
  • Mechanical separation of PRP using a chemically inert separator gel after 5-minute centrifugation at 1500g
  • Pharmaceutical grade solution of sodium citrate allowing a reversible anticoagulation
  • Minimal learning curve and ease of use
  • Operationally and clinically efficient process
  • Facilitates and streamlines routine practice

Biological advantages

  • RegenPRP® is standardised, leucocyte-reduced, and easily reproducible with RegenLab®’s specific separator gel technology, ensuring minimal variability
  • Platelet recovery > 80%
  • High platelet quality. Viable & functional
  • Full plasma recovery. No loss of plasma growth factors and fibrinogen
  • Leucocyte-reduced PRP. Depletion of pro-inflammatory granulocytes, leaving mainly lymphocytes and monocytes
  • Virtually no red blood cells.

Scientific advantages

  • Demonstrated safety and efficacy
  • Evidence-based outcomes for numerous therapeutic indications
  • Clinical studies, with over 200 publications

Related products

Connect the right product to the best-suited technology

About Us

Since 2003, Regen Lab SA has specialized in designing and manufacturing high-quality medical devices for cell therapies and the preparation of autologous platelet-rich plasma (PRP) from the patient's own blood for bedside procedures.

Milestones

2003 - Foundation
2010 - RegenKit first approval in bone graft
2013 - A new state-of-theart laboratory in Lausanne
2014 - Cellular Matrix first approval
2015 - Launch of Cellular Matrix in Europe

Vision

Founded in 2003, Regen Lab has become a global reference thanks to its commitment to innovation, quality, and the effectiveness of its therapeutic solutions. Here’s how we have transformed the medical landscape over the past two decades.

RegenPRP™

RegenPRP™ is a medical treatment that uses platelet-rich plasma from the patient's own blood to enhance and tissue regeneration.

RegenPRP™ - HA

RegenPRP™ - HA combination is an innovative treatment combining platelet-rich plasma (PRP) and hyaluronic acid to improve tissue regeneration and healing.

RegenPRP™ - ATS

RegenPRP™ combined with ATS (Autologous Thrombin Serum) is an advanced approach to tissue regeneration that uses autologous thrombin-enriched platelet-rich plasma (PRP) to maximise healing effects.

RegenExtracell®

RegenExtracell is an innovative tissue regeneration treatment using an extracellular matrix enriched with platelet-rich plasma (PRP).

Hyaluronic Acid

Coming Soon

Regulatory

Manufacturers of medical devices based outside the EU must designate an Authorized Representative (EC-REP) established within the EU in order to meet the CE requirements for placing medical devices on the EU market.

Quality Management

Regen Lab Quality System Management ensures the consistency of our products quality in total GMP compliance.

Our production facility rooms atmosphere is monitored to satisfy non-pyrogenic medical devices manufacturing.

Patents

As a leader in the PRP&HA regenerative field and as an innovation-driven company, Regen Lab SA has devoted important resources since 2004 to put on the market pioneering and diversified products constituting a complete set of tools/technologies for the medical community.